You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

ALCAINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Alcaine, and what generic alternatives are available?

Alcaine is a drug marketed by Alcon Labs Inc and is included in one NDA.

The generic ingredient in ALCAINE is proparacaine hydrochloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the proparacaine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Alcaine

A generic version of ALCAINE was approved as proparacaine hydrochloride by BAUSCH AND LOMB on September 29th, 1995.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ALCAINE?
  • What are the global sales for ALCAINE?
  • What is Average Wholesale Price for ALCAINE?
Drug patent expirations by year for ALCAINE
Recent Clinical Trials for ALCAINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Buddhist Tzu Chi General HospitalEarly Phase 1
William Beaumont HospitalsPhase 4
Louisiana State University Health Sciences Center in New OrleansPhase 4

See all ALCAINE clinical trials

Pharmacology for ALCAINE
Drug ClassLocal Anesthetic
Physiological EffectLocal Anesthesia

US Patents and Regulatory Information for ALCAINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Labs Inc ALCAINE proparacaine hydrochloride SOLUTION/DROPS;OPHTHALMIC 080027-001 Approved Prior to Jan 1, 1982 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.